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The Effects of Selected Drugs on the Memory Recall of Sleep Deprived Mice
Jennifer Pauldurai
Abstract: Humans often make use of the neurotransmission altering effects of drugs
such as caffeine, ephedrine, and ethanol. These drugs induce changes in memory
and learning ability, specifically when used for sleep deprivation (Pilcher &
Huffcutt, 1996; Malinauskas, Aeby, Overton, Carpenter-Aeby, & Barber-Heidal,
2007). English white mice (Mus musculus) have been shown to exhibit similar
cognitive changes when administered drugs or when sleep deprived (Tanaka et al.,
2003; Vecsey et al., 2009; Patti et al., 2010). This study revealed a counterbalancing
effect when mice were both administered selected drugs and sleep deprived. A
sample of 20 mice was divided into three experimental groups (each group receiving
one of the following drugs: caffeine, ethanol, or ephedrine) and one control group.
Maze-testing demonstrated that memory performance decreased with sleep
deprivation (Treatment-1) but all groups returned to baseline performance when
injected (IP) with their selected drugs (Treatment-2), regardless of the specific drug.
However, in the absence of sleep deprivation, each drug showed less of an effect.
Neither caffeine nor ephedrine produced any significant effect, while alcohol
treatment decreased performance. Overall, sleep deprivation consistently decreases
memory recall performance in mice. Drug use can counterbalance those effects of
fatigue. However, that drug use does not have the same effect on non-fatigued mice,
which suggests a synergistic interaction between sleep deprivation and the use of
these specific drugs.
Modern society has seen an increased prevalence of cognitive improvement methods and
it seems that everyone is intent on maximizing their brain power. Memory recall has been
particularly targeted by those under the demands of the academic environment (Pilcher &
Huffcutt, 1996). The recall ability of the average college student is influenced by many
behavioral and chemical factors. This population has been known to regularly make use of
chemicals such as caffeine, alcohol and more recently, ephedrine. Caffeine is found in many
beverages, including coffee, teas, and soda. Similarly, alcoholic beverages are prevalent in the
party and nightlife scenes of college environments. Less advertised, but still widely abused, is
ephedrine, which is the chemical basis of many study aids and ADHD drugs, such as Adderall
and Ritalin (Durmer & Dinges, 2005; Pilcher & Huffcutt). In addition to these drugs, college
brains are exposed to chronic sleep deprivation. The dynamics of exposing the brain to all of
these circumstances can affect the limits of memory recall.
Previous research has well documented the independent physiological effects of caffeine,
ethanol, ephedrine, and sleep deprivation on mice. Research was compiled using academic
journals and databases such as PSYCHBooks, SAGE, and Web of Knowledge. Keywords used in

this literature review were: caffeine, ethanol, ephedrine, sleep, mice, Mus musculus, cognition of,
memory recall of, sleep deprivation, fatigue, stimulants on, drug use of, and learning ability of.
The following review highlights the results of this literature search and will lay a foundation for
the experimental procedure of this research study. Studies will be presented first on sleep
deprivation and its effects in both humans and mice. Studies will then be presented more
specifically on each of the drugs that will be tested. This information will provide more
background details on the specifics behind the behavioral test results.
English white mice (Mus musculus) have often been used as the behavioral model for
cognition and memory recall experiments simply because of the similarities in learning and brain
functioning between this animal model and human behavior. Mice learn quickly and have many
of the same neurotransmitter activities as the human brain. Mice also have been widely used as
the model for fatigue and sleep deprivation (Tanaka et al., 2003; Vecsey et al., 2009; Patti et al.,
2010). Their light/dark schedules for sleep-wake cycles allow for easy manipulation and control
over the amount of sleep, and correspondingly, the amount of fatigue that each mouse is
subjected to (Dall’Igna et al., 2003). Additionally, administration of drugs into the mouse
environment can be controlled for accurate experimentation. Mice can be introduced to selected
chemicals in various ways. Mice can ingest drugs ad libitum through their diet or the drugs can
be measured out and injected into the mouse’s bloodstream. Use of these methods has shown
success in altering the brain chemistry of mice. Aptly, mice have often been used in drug studies
as their behavior is readily testable and the effect of the drug on the physiology of Mus musculus
is similar to the behavioral changes expected in the human population (Tanaka et al.).
Sleep Deprivation in Mice
Mice sleep for approximately 85% of their day and sleep deprivation is defined as loss of
this regular amount of sleep. The causes of this behavior are usually laboratory induced and not
the result of voluntary decisions to stay awake on the part of the mouse. Deprivation can range
anywhere from four hours to 10 hours of no sleep or partial sleep in the sleep-wake cycle
(Tanaka et al., 2003). Ten hours of total sleep deprivation has shown a change equivalent to that
of about a week of limited sleep in the human population (Kayir & Uzbay, 2004). The effects of
sleep deprivation in mice are similar to those found in humans in that this behavior can induce
restlessness, lack of coordination, forgetfulness, distractibility and longer reaction times.
Cognitively, sleep deprivation can cause attention deficits and a lack of concentration, with an
increased number of errors and memory disturbances. Long term effects of this behavior include
high blood pressure, obesity and diabetes in both mice and humans (Hunt, Momjian, &Wong,
2011; Patti et al., 2010).
Physiology of Sleep Deprivation and Fatigue
In mice, sleep deprivation can cause irreversible changes in hippocampal potentiation
activity. Fatigue reduces cortical activity and dendritic spine formation. Fatigue also changes the
amounts of tryptophan, indoleamines and catecholamines available for cell signaling. These are

all involved in the regulation of melatonin levels (Tanaka et al., 2003; Vecsey et al., 2009).
Serotonin levels are also affected by decreased levels of sleep and this in turn affects other
hormonal levels including those of dopamine, cortisol, and glucose. Glucose uptake is a primary
indicator of brain activity in PET scans and other systemic brain scans. Thus a PET scan run on a
sleep deprived mouse brain would exhibit very little overall activity. One study also showed that
sleep deprivation interferes with cyclic AMP signaling pathways in the hippocampus of mice.
Cyclic AMP is a vital secondary messenger not only in hippocampal signaling but also in
numerous other intracellular and intercellular pathways (Tanaka et al.).
Sleep Deprivation and Learning
Beyond the effects on memory of sleep deprivation and fatigue, there are also changes in
learning, which is intimately connected with recall ability. Some research suggests that sleep
deprivation has such a large effect on learning in part because of the state-dependency of
learning (Patti et al., 2010). The fatigue level while the mouse is initially learning is different
from the fatigue levels during recall: this inconsistency of mental environment interferes with
learning efficiency. Also, because the efficiency of learning is directly linked to memory recall,
changing chemical levels with the sleep deprivation alters the memory ability before recall is
even initiated. Thus the effects of sleep deprivation are two-fold: this behavior alters the learning
state before memory recall and the ability of the mouse to retrieve information after it has been
stored in memory (Patti et al.).
Sleep Deprivation Methods
There have been several documented methods of depriving mice of sleep. Total sleep
deprivation can be induced by procedures involving water. The disk-over-water method involves
a motor that plunges the mouse into water if a decrease in electromagnetic activity is detected.
Mice can also be inactively submerged in water for a period of time—or forced to keep moving
by rising levels of water (Ruiz-Medina, Pinto-Xavier, Rodriguez-Arias, Minarro & Valverde,
2012). This use of water is justified in that mice cannot comfortably sleep while under the stress
and fear of drowning, as well as the change in temperature, humidity, and wetness that alter the
specific environmental specifications that mice need for sleep (Chen et al., 2009).
Other methods of sleep deprivation include the removal of bedding and the changing of
the sleep-wake cycle to include more light hours (Tanaka et al., 2003). Mus musculus is sensitive
to environmental changes and responds to disturbances by staying alert for any potential dangers.
Gentle tapping or gentle handling involves the use of a brush to gently nudge the mouse awake if
fatigue and napping is observed, but this method is tedious and time consuming on the part of the
experimenter. Newer, more automated methods include the use of chambers that measure brain
activity and correspondingly change the environment without the need for the subjectivity of
observation (Chen et al., 2009; Tanaka et al.).

Pharmacology and Usage of Caffeine
Caffeine is a chemical that has a stimulatory effect on brain activity. This effect is
accomplished through two mechanisms. Firstly, caffeine antagonizes the binding of adenosine to
receptors thus blocking the inhibitory effect of adenosine and allowing for increased flow of
neurotransmitters such as norepinephrine, cortisol and acetylcholine. With the muted influence
of adenosine, the brain increases in energy exchange and is more alert and responsive to stimuli.
At higher dosages, caffeine can also block other neurotransmitter reception, such as GABA, and
this can cause increases in respiration and heart rate (Ruiz-Medina et al., 2012). Caffeine has also
been shown to affect metabolic rate. Caffeine is a xanthine which means it acts as a
phosphodiesterase inhibitor allowing for an increase in the levels of free fatty acids in the
bloodstream. This decreases the necessity for the breakdown of stored fats and energy is readily
available from the increased oxidation of the free fatty acids. This sudden abundance of energy
can account for the jittery, hyper-alert, wakefulness associated with caffeine usage (Ruiz-Medina
et al.).
The lethal dosage (LD50) of caffeine for mice has been measured to be 168 mg/kg of
body mass. The stimulant and depressant effects of caffeine on the mouse can be observed in
changes in locomotor behavior well before the LD50 concentration. This can be observed in the
laboratory setting and to a much lesser extent in the open field (Ruiz-Medina et al., 2012).
Pharmacology of Ephedrine
The mechanism of action of ephedrine is an indirect stimulation of the adrenergic
receptor system. As a sympatomimetic, ephedrine will bind to alpha and beta receptors of
noradrenaline and stimulate the release of noradrenaline and dopamine. Both of these
neurotransmitters have stimulating effects on the nervous system and have been known to clear
up asthmatic sinuses and induce weight loss, as well as increase cognitive ability in humans.
(Blizard, 2007). Similar bronchodilation and weight loss effects are expected of mice. Ephedrine
has also been used to observe energy dynamics using mice models. The LD50 of ephedrine in the
mouse is 55.74 mg/kg of body mass. (Malinauskas et al., 2007; Dullo & Miller, 1986).
Pharmacology and Usage of Ethanol in the Mouse
Ethanol is a depressant that binds to several neurotransmitter receptors and limits their
activity. Effected neurotransmitters and hormones include acetylcholine, GABA, serotonin and
NMDA (Dullo & Miller, 1986). This antagonistic activity also stimulates an increase of
dopamine levels, allowing for the initial euphoric feeling (Hunt, Momjian, & Wong, 2011;
Carvalho et al., 2012). However, the nervous system is suppressed overall, which can lead to the
uninhibited behavior of the subject administered ethanol. Alcohol can be similarly administered
to mice below an LD50 level of 0.0066mg/kg of body mass. Mice are susceptible to overdose but
also susceptible to tolerance over time (Carvalho et al.). Mice will choose to voluntarily partake
of alcohol after addiction. Similarly to humans, inhibition-free activity is reported in mouse
behavior after alcohol usage.

Critique of the Literature
The studies appear to validate the mice model as appropriate for empirical study because
mice effectively model both sleep deprivation and selected drug use in a controlled environment
while allowing for the easy testing of memory recall. The changes in memory can be
behaviorally tested and the effects of these various drugs and fatigue can be behaviorally
observed. The relationship between caffeine, ephedrine, and ethanol, and memory recall has been
established and explained (Dullo & Miller, 1986; Hunt, Momjian, & Wong, 2011; Carvalho et
al., 2012; Malinauskas et al., 2007; Blizard, 2007; Ruiz-Medina et al., 2012). Similarly, the
relationship between sleep deprivation and cognition has also been modeled and
neurobiochemically understood (Tanaka et al., 2003; Vecsey et al., 2009; Patti et al., 2010;
Dall’Igna et al., 2003; Kayir & Uzbay, 2004; Hunt, Momjian, &Wong, 2011; Chen et al., 2009).
Major strengths of these studies include the abundance of information on testing and
observing these behavioral changes. The methods have ranged from dissection to observation to
computer monitoring of electromagnetic brain activity. Despite this range of methods, almost all
research has agreed on the behavioral effects that can be induced in the mouse by the factors of
fatigue and drug usage.
Weaknesses in the research include a lack of variety of drugs tested and administered to
mice. Well-documented drugs include ecstasy, dopamine derivatives and medications. More
pertinent drug choices could have been the testing of energy drinks such as Red Bull or the
commonly used ADHD drug, Adderall. These would provide more relevant information on the
human behavior and use of drugs. Another gap in the studies is the lack of information on the
synergistic effects of combining any of these drugs. Rarely are any of these stimulants or
depressants taken independently. Alcohol consumption is often tied intimately with other drug
use in the human population. Modeling these interactions would provide a more realistic
simulation of the brain environment.
This current study is a behavioral study using male English white mice (Mus musculus) to
address the latter gap in that it will combine the effects of sleep deprivation with the effects of
drug usage to see what this combined interaction will do to the memory recall of mice. This
mixture of two factors will hopefully model the dynamics of some of the common chemical
interactions on college campuses.

Definition of Terms
In this study, the following terms will be operationally defined:
1. Sleep deprivation is defined as the partial control of no sleep. This will be induced by
the removal of bedding and the gentle tapping method. Deprivation will be
observationally determined by the mouse behavior indicative of sleep: closing of eyes,
heavy breathing, curling of the body and limited movement. This direct observation
method is utilized for five of the ten hours of deprivation and it is assumed that for the
remaining five hours, mice did not rest and were indeed sleep deprived.

2. Maze success is defined as the completion of the maze when the mouse has successfully
found the food and begun eating. Merely sniffing the food reward does not deem
successful completion of the maze. This is a measurement of time in seconds.
3. Gait is defined as the pace and movement of the mouse through the maze. This will be
determined by relative speed of movement.
4. Decision making is defined as the number of times that the mouse enters a maze arm.
The mouse does not need to reach the end of the arm to be considered having turned
into the arm. A change in decision making is therefore when a mouse enters an arm and
then exits to enter the other arm.
5. A mistake is defined as every time a mouse enters the arm which does not contain the
reward.
6. Learning resistance is defined as the inability of the mouse to locate the correct arm
with the reward within 120 seconds.
7. Fatigue is defined as tiredness induced by sleep deprivation and is presented and
observed in these forms: slower than normal gait, light breathing, barely open eyes, lack
of reaction to touch, decreased reaction times and decreased overall movement.
Hypotheses
Seven research hypotheses were addressed in this study. Each of these hypotheses was tested in
its null form.
1. There are no pre-existing statistically significant differences among the drug groups at
the baseline treatment (Treatment-0).
2. There are no pre-existing statistically significant differences within the control group
over the course of the three treatments.
3. Sleep deprivation (Treatment-1) does have a statistically significant effect across all test
groups.
4. Drug injection does have a statistically significant effect across all test groups.
5. Drug injection plus sleep deprivation (Treatment-2) has a statistically significant effect
across all test groups.
6. There is a statistically significant difference in effect among the different drug treated
groups administered during Treatment-2.
7. There is a statistically significant difference in effect among drug treated groups,
independent of Treatment-1.
Method
Subjects
Twenty adult male English Mice (Mus musculus) were the main subjects of this study.
This was a sample of convenience and was assumed to be representative of the behavior of mice
in the general population. Each mouse was randomly assigned to one of four different groups:
three test groups (CAFF, ETOH & EPHD) and one control group. These mice were bought from

the same litter at Petco Incorporated. (Chattanooga location on Gunbarrel Road). All mice were
ethically handled and housed according to the Core Values Statement and Code of Ethics of the
American Association of Laboratory Animal Science (AALAS, 2013) and according to the
Responsible Conduct of Research published by the American Psychological Association (APA,
2010). No human subjects were involved.
Materials and Apparatus
A standard Y-arm maze made out of 2 cm thick opaque plastic was used for testing. Each
of the three arms of the maze was approximately 0.305 meters in length (1 foot). The maze was
set atop a cardboard floor for easy traverse. Certified rodent diet, water, bedding and an exercise
wheel were available ad libitum to ensure a controlled environment while non-testing. Plastic
rodent carrier cages with aerated lids were used to house the mice. The mice cages were stored
on a cart with a blanket used to control the sleep-wake cycle.
A timer was used as necessary during testing—this was not in physical contact with the
animals. During testing, the same food source was used as a reward in the behavioral maze
testing. Sterile 27-gauge hypodermic needles and 1-ml syringes were used for the intraperitoneal
injections. Injected chemicals included 200 mg of caffeine in tablet form (Jet-Alert, OTC boxes),
5 ml of ethanol (Smirnoff Vodka, 100 proof), 20 ml natural saline (0.9%), and 200 mg of
ephedrine in tablet form (Pseudofed, OTC boxes). The reward used in the maze was the same
odorous, certified rodent diet used in housing. Cleaning supplies as necessary were used to keep
the mice housed in clean environments.
Design and Procedure
This study was a blind between-subjects experiment. Each of twenty English mice (Mus
musculus) was randomly assigned to one of four groups: the first group was the control (CTRL,
n = 5); the second group was the caffeine group (CAFF, n = 5); the third group was the ethanol
group (ETOH, n = 5); and the final group was the ephedrine group (EPHD, n = 5). The mice
were caged at the Psychology Resource Area in Herin Hall. During the training and testing
phases they were transported to the Biology Department in Hickman Science Center where
testing occurred in open laboratory space. All interaction with the mice was limited to these two
sites on the campus of Southern Adventist University.
Treatment-0. All 20 mice were allowed to situate and acclimate to the new environment
and diet for approximately one week. After this time period, mice were introduced to the Y-maze
in the learning phase of this experiment. Each mouse was placed in the Y-maze in a quiet and
non-distracting environment. The time that the mouse traverses the maze was recorded until the
mouse finds the food that was placed as a reward at the end of one arm. Discovery of the food
was marked by the ingestion of food, not just the sniffing of food. Mice were declared learning
resistant if they did not find the food within 120 seconds. This procedure was repeated three
times for each mouse to ensure learning. This phase was done at the same time of day and after a
one meal fast to induce hunger in the mice.

Treatment-1. Testing began 48 hours after all the mice had undergone learning. CTRL
mice remained in their housing to be well rested for this time interval and were retested for
memory recall of the same Y-maze exactly 48 hours after training. CAFF mice remained in their
housing until a 10 hour period before their testing. In this ten hour period, all bedding was
removed and lights were kept on. For the last five hours of this deprivation period, intermittent
gentle handling of mice added to the partial sleep deprived environment. Testing ensued for each
mouse individually immediately after this partial sleep deprivation state. The testing procedure
mimicked the training procedure in that mice were given 120 seconds to find the food, three
times. The maze was wiped down with sanitizing alcohol to reduce any scent trails. There was
ample time for the alcohol to evaporate before mice were reintroduced to the maze. This
procedure was repeated with the ETOH and EPHD groups as well. Mice were returned to a
normal sleep-wake and diet environment as soon as testing was complete.
Treatment-2. Testing began 48 hours after all the mice had undergone Treatment-1.
CTRL mice remained in their housing to be well rested for this time interval. Immediately after
their rest period, the CTRL mice were injected with approximately 0.2 ml of 0.9% natural saline.
The mice were then retested for memory recall of the same Y-maze according to the protocol
listed in Treatment-1. Similarly, CAFF mice were sleep deprived for the immediate 10 hour
period before testing. This sleep deprivation involved the same protocol of removing bedding
and gentle handling as listed in Treatment-1. Immediately after sleep deprivation, each mouse
was removed from the cage and injected with a caffeine solution. Caffeine solutions were
prepared from a mix of natural saline (0.9% NaCl) and dissolved caffeine tablet at a ratio of
0.2mg of caffeine/0.2 ml of saline. This solution was an intraperitoneal injection with a volume
of 10 ml/kg (approximately 0.2 ml per mouse). This concentration is midway between the
effective dose and the lethal dose of caffeine for mice. After the injection of the caffeine
solution, mice were returned to their cages for a 30 minute reaction period. After observational
recordings during this time, testing followed the same procedure as the previous two treatments.
ETOH mice were sleep deprived for 10 hours as well and then injected with the ethanol
solution. The ethanol solution was prepared using 0.2 mL of pure ethanol in 0.8 mL of reverse
osmosis water for a 20% ethanol solution. This concentration is midway between the effective
dose and the lethal dose of ethanol for mice. This was also an intraperitoneal injection with a
volume of 10 ml/kg (approximately 0.2 ml per mouse). EPHD mice were similarly sleep
deprived. The ephedrine solution was prepared by mixing 5 mg of synthetic ephedrine in 1 mL
of 5% sucrose water. This injection was not weight-dependent and a constant 0.02 mL of
solution was injected into each mouse. A similar procedure for injection and sleep deprivation
was maintained for all three experimental groups. A 30 minute wait period was also maintained
for all test groups. Injections were all intraperitoneal with each mouse injected with a clean
needle. Mice were restrained by hand without the use of anesthetics during the injection and all
other transporting involved carefully picking up the mice from the base of their tails. All mice
were returned to housing after Treatment-2.

Additional control measures. After 48 hours of recovery, mice performed the final step
of testing. This run was a secondary control measurement with the maze testing done after the
mice were well-rested, with a one-meal fast. After proper recording and cleanup, mice were
returned to housing for recuperation. Testing was then complete and mice were appropriately
disposed of.
Data Analysis
After data collection, four dependent sample t-tests were conducted relating Treatment-0
and Treatment-1. This procedure was repeated between Treatment-1 and Treatment-2, and
between Treatment-0 and Treatment-2. A one-way ANOVA was run on the differences in
medians between Treatment-1 and Treatment-0 to determine the effect of each test group. This
procedure was repeated for the differences in medians between Treatment-2 and Treatment-1.
Results
The sample of 20 mice had a total of 56 trials instead of 60 trials due to subject sickness.
Means and medians were calculated according to each test group and each treatment. Overall,
learning took approximately 37.0 seconds for each mouse. After Treatment-1, memory recall of
the maze was approximately 37.5 seconds. After Treatment-2, overall average maze completion
was clocked at 35.4 seconds. Changes within each group are further analyzed below and in the
Appendix in Tables 2-4, as well as in Figure 1.
Hypotheses
1. There were no statistically significant differences among the drug groups at the baseline
treatment (F = 1.09, p = 0.36). The one-way ANOVA showed that there was insufficient
evidence to reject the null hypothesis. This means that there were no significant preexisting differences between the mice before treatment began.
2. There were no statistically significant differences within the control group over the
course of the three treatments (F = 0.14, p = 0.87). The one-way ANOVA showed that
there was not sufficient evidence to reject the null hypothesis. This means there were no
differences among the control group over the three treatments.
3. Treatment-1 does have a statistically significant effect across test groups (r1 = -0.35, k1
= 45, p1 = 0.02; r2 = -0.22, k2 = 45, p2 = 0.14; r3 = 0.40, k3 = 42, p3 = 0.01). Pairedsample t-tests were conducted for each drug group with group-specific number of trials
(k). There was sufficient evidence to reject the null hypothesis, suggesting that there is a
difference induced by Treatment-1. Sleep deprivation did have a statistically significant
effect on the memory recall of all the tested mice (See Figure 1).
4. Treatment-2 did not have a statistically significant difference from Treatment-1 across
any of the test groups (r1 = 0.25, k1 = 30, p1 = 0.19; r2 = 0.26, k2 = 30, p2 = 0.17; r3 = 27,
k3 = 27, p3 = 0.08). This series of paired sample t-tests for each test group did not
provide enough evidence to reject the null hypothesis. This suggests that the drug

treatment of Treatment-2 did not have a significant effect on the memory recall of the
sleep deprived mice (See Figure 1).
5. Treatment-2 did not have a statistically significant difference from baseline treatment
across any of the test groups (r1 = -0.15, k1= 45, p1 = 0.34; r2 = 0.12, k2 = 45, p2 = 0.45;
r3 = 0.02, k3 = 39, p3 = 0.90). This next series of paired sample t-tests for each test group
did not provide enough evidence to reject the null hypothesis. This means that there was
no significant difference between the well-rested mice and the sleep deprived plus drug
treated mice (See Figure 1).
6. There are no statistically significant differences in effect between the different drug
treated groups administered after Treatment-2 (F = 0.62, p = 0.61). The one-way
ANOVA did not provide enough evidence to reject the null hypothesis, suggesting that
there were no differences among the drug treated groups. Each drug had the same effect
regardless of the chemical substance (See Figure 1).
7. There is a statistically significant difference in effect among drug treated groups,
independent of Treatment-1 (F = 3.81, p = 0.02). The one-way ANOVA on the
differences between Treatment-1 and Treatment-2 showed that there was enough
evidence to reject the null hypothesis. This means there was a difference among one or
more of the drugs in the absence of sleep deprivation. The only significant difference in
this test was as a result of the ethanol treatment. Ethanol was statistically different from
the control, caffeine, and ephedrine treatments (See Figure 2).
Other Interesting Findings
Several mice were resistant to learning and these trials were not taken into consideration
when calculating means and medians. Other trials showed evidence of outliers in each test group,
where some mice would find the food incredibly quickly (M = 4.0 seconds) and because of these
outliers, medians were reported when running ANOVA analysis.
Summary of Results
Baseline treatments were approximately the same across all the groups, ensuring that no
one group of mice had a pre-existing advantage. Sleep deprivation in Treatment-1 had a negative
effect on the memory recall of the treated mice. Treatment-2 was statistically identical to
Treatment-0. This suggests a return of memory recall performance to baseline efficiency after the
negative plunge of sleep deprivation. When combined with sleep deprivation, no one drug group
was more efficient at restoring performance. However, when administered independently of
sleep deprivation there were differences in the effects of the drugs. These results are further
summarized in the following Table 1.

Table 1
Research Hypotheses in Summary
Hypothesis
Expected
Actual
Result
1. No differences at baseline.
p > 0.05
p > 0.05
Hypothesis Supported
p > 0.05
Hypothesis Supported
2. No differences in CTRL.
p > 0.05
p < 0.05
Hypothesis Supported
3. Sleep deprivation causes change.
p < 0.05
4. Drug use causes change.
p < 0.05
p > 0.02
Hypothesis Rejected
p < 0.05
p > 0.02
5. Drug use + deprivation causes change.
Hypothesis Rejected
6. Each drug group causes different change
p < 0.05
p > 0.02
Hypothesis Rejected
in sleep deprived mice.
7. Each drug group causes different change
p < 0.05
p < 0.05
Hypothesis Supported
in well-rested mice.
Note: The phrase “causes change” indicates a statistically significant difference within or
between the results as suggested by a t-test or an ANOVA. The presence or lack of “change”
does not correlate with the presence or lack of an effect.
Discussion
The purpose of this study was to quantify the effects of drug use on the memory recall of
sleep deprived mice. Three different drugs were used: caffeine, ethanol, and ephedrine. These
drug treatments were combined with experimental sleep deprivation methods. Over the course of
the experiment the effect of this combination on memory recall was measured using a Y-maze.
The research hypotheses first established that the changes in memory recall were indeed a result
of the treatments. There were no differences among the mice; all changes could be attributed to
the methods and no genetic predisposition provided an unfair advantage. The next set of research
hypotheses addressed the changes induced over the course of the three treatments. The results
show that sleep deprivation does have a negative effect on the memory recall of mice with very
little variability. This negative change was counterbalanced by the injection of the selected drugs
in Treatment-2. The differences between baseline (Treatment-0) and Treatment-2 were
essentially negligible. Upon first glance this could be misinterpreted to mean that the
combination has no effect on memory recall. However, looking at Treatment-1 shows that sleep
deprivation does in fact have an effect and that effect was just reversed upon the additional drug
treatment.
Surprisingly, there were no differences in effect between the drugs used in Treatment-2.
It was hypothesized that all three drugs would have an effect significantly different from
baseline. Because caffeine and ephedrine are stimulants, these two drugs were anticipated to
show a greater than average memory recall efficiency and performance would be enhanced
beyond the baseline. Similarly, because alcohol is a depressant, it was predicted to have
depressing effects and memory recall would be further stunted by the ingestion of alcohol.

However this was not the case. All three drugs had the same effect on sleep deprived mice,
returning memory recall performance to baseline efficiency.
Upon further statistical analysis examining the differences between sleep deprivation and
the combined treatments, it was seen that the drugs had different effects independent of sleep
deprivation. This leads to two general conclusions. One, the combined effects induced by sleep
deprivation and drug use were not equally split between the two factors. In some test groups
(specifically the caffeine and ephedrine groups), the drugs played a large role in
counterbalancing the sleep deprivation. However, in the ethanol test group, sleep deprivation had
the greater effect of memory recall and the combination of the two factors was more synergistic
than either of the factors alone. This is seen in the results of Treatment-2 minus Treatment-1. The
drugs had different effects when they were not acting in conjunction with sleep deprivation.
Caffeine and ephedrine had very little significant effects on memory recall and alcohol treatment
had a significantly negative effect on overall memory recall. This finding suggests that drugs
may have varying effects on cognition that is already varied on other factors such as sleep
deprivation.
These findings are based on the repeated trials of twenty mice which is a relatively small
sample size and may not actually be representative of the mice population, much less human
cognition. Additionally, the methods used in this experiment may not be valid with every animal
study. Sleep deprivation was induced with the removal of bedding but there was no camerarecording device to ensure that the mice were actually sleep deprived. Along the same lines,
there was no drug-only treatment to test the effects of drugs on the well-rested mouse. These
results were surmised using the means obtained from the combined treatment and the sleepdeprivation only treatments. The introduction of a drug-only treatment brings to light the need to
control for order effects. Drug-only before fatigue-only could be a different effect than the
opposite chronological order. With more time and resources, perhaps this weakness could be
addressed in future studies.
Future studies could also address a great range of variable drugs. Energy drinks and sugar
are also greatly abused on college campuses and these could have a large influence on memory
recall as well as on sleep patterns. Another angle for future research could be the alteration of the
concentrations of drugs and the introduction of each drug at different time increments. This study
did not address external factors such as addiction and repeated exposure and these could also be
points of interest in future studies. This study did however validate the use of the mouse model
of sleep deprivation and these findings contribute to the knowledge of stimulant use on cognitive
performance. This mice model could provide information for commonly sleep deprived
populations, such as college communities and emergency personnel. Results suggest that if sleep
deprivation is absolutely necessary, the consumption of any of the three selected drugs could
potentially counterbalance the negative memory recall performance associated with fatigue. This
study addresses gaps in previous research that documented the effects of either one or the other
but not the combination of sleep deprivation and drug use. Focusing on the combination not only
provides empirical information on the science of drug abuse but it also introduces new methods

of approaching experimental methodology testing several variables and the overall significance
of each variable.
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Appendix
Table 1
Research Hypotheses in Summary
Hypothesis
Expected
Actual
Result
1. No differences at baseline.
p > 0.05
p > 0.05
Hypothesis Supported
p > 0.05
Hypothesis Supported
2. No differences in CTRL.
p > 0.05
3. Sleep deprivation causes change.
p < 0.05
p < 0.05
Hypothesis Supported
4. Drug use causes change.
p < 0.05
p > 0.02
Hypothesis Rejected
p < 0.05
p > 0.02
5. Drug use + deprivation causes change.
Hypothesis Rejected
6. Each drug group causes different change
p < 0.05
p > 0.02
Hypothesis Rejected
in sleep deprived mice.
7. Each drug group causes different change
p < 0.05
p < 0.05
Hypothesis Supported
in well-rested mice.
Note: The phrase “causes change” indicates a statistically significant difference within or
between the results as suggested by a t-test or an ANOVA. The presence or lack of “change”
does not correlate with the presence or lack of an effect.

Table 2
Treatment-0: Mean Completion Times in Seconds
Average
Test Group
Trial 1
Trial 2
Trial 3
25.3
Control
31.0
17.9
27.0
39.3
Caffeine
41.2
33.2
43.6
37.0
Alcohol
30.9
41.9
38.3
29.3
Ephedrine
31.8
22.4
33.6
Note: Testing Hypothesis #1 suggests that the differences between these averages are not
statistically significant. In effect, there are no differences between any of the groups at baseline.

Table 3
Mean Differences in Completion Times Between Treatment-0 and Treatment-1
Test Group
Control
Caffeine
Alcohol
Ephedrine

Trial 1
-11.2
-23.6
1.1
-3.6

Trial 2
14.1
-23
11.1
-5.4

Trial 3
-4.6
-19.4
-20.1
-17.6

Average
-0.6
-22.0
-2.6
-8.9

Note: Testing Hypothesis #2 suggests that the average change seen in the Control group is not
statistically significant. Testing Hypothesis #3 suggests that the average changes seen in the three
test groups are significant differences from Treatment-0.

Table 4
Mean Differences in Completion Times Between Treatment-0 and Treatment-2

Change in Median Completion
Times (s)

Test Group
Trial 1
Trial 2
Trial 3
Average
Control
-16.8
-1.9
13.8
-1.6
Caffeine
-13.8
-13.0
-3.4
-10.1
Alcohol
-15.6
-23.3
-29.9
-22.9
Ephedrine
23.8
21.8
-8.8
12.3
Note: Testing Hypothesis #5 suggests that these average changes are not statistically different
from Treatment-0. In effect, these results are equivalent to the averages seen at baseline.
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Figure 1. Memory recall measured by maze completion time in seconds.
Note: The change in median maze times per test group is indicated by different colors. The
horizontal axis shows the progression of treatments in each repeated measures design. The
differences among the three test groups after Treatment-1 and after Treatment-2 were not
statistically significant at α = 0.05 (k= 57, F = 0.62, p = 0.61).
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Figure 2. Comparison of maze completion times between Treatment -1 and Treatment-2.
Note: This compares the effect of the drug treatments, independent of the sleep deprivation. The
only significant result among the three test drugs was due to the ethanol treatment (α = 0.05, k =
57, F = 3.81, p = 0.02).

